Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The aim of the Malaria & Critical Illness Department at MORU is to improve health through research that addresses threats arising from malaria for billions of people who live in malaria endemic zones around the globe.

A group photo of Arjen Dondorp, Head of Malaria with Kesinee Chotivanich and her Malaria Lab team. © MORU 2019. Gerhard Jørén
Arjen Dondorp, Head of Malaria (back right) with Kesinee Chotivanich (front, 2nd right) and her Malaria Lab team.

Overview Malaria & Critical illness

Billions of people live in malaria endemic countries; we aim to improve health through research that addresses this threat.

Critical illness Malaria & Critical illness

The Wellcome-MORU supported CRIT Care Asia (CCA) platform enables International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) and WHO compliant real-time reporting of severe acute respiratory infections (SARI) critical care admissions from 11 South Asia and sub-Saharan African countries. CCA COVID -19 data is contributing to local, national and international research, and supporting service delivery. CCA is a collaborator of LOGIC, an international quality improvement consortium of ICU registries spanning four continents.

Significant achievements Malaria & Critical illness

The Malaria & Critical Illness team published 96 papers in 2018, and 222 papers from 2015-2017, of which many in leading journals. Since its conception in 1979, the Malaria team has published over 1,000 papers.

Future vision Malaria & Critical illness

Following the large multi-centre multi-country TRAC II study on triple ACTs (TACTs) to treat multi-drug resistant falciparum malaria, DeTACT, a large project funded by DFID, will expand the evaluation of TACTs to African countries and aims to have 2 different TACTs ready for deployment by the end of the project.

Studies & study sites - Malaria & Critical illness

The Malaria & Critical Illness Department has a vibrant and productive network of collaborative study sites throughout South-East Asia, South Asia and Africa, with around 15 studies currently operating in a total of an equal number of countries.